MD Anderson Cancer Center

Today, we broke ground today on our new 470,000-square-foot facility in Sugar Land. This new five-story facility will offer expanded services, including surgery, imaging and radiation, bringing comprehensive cancer care closer to home for patients in southwest Houston. Our new Sugar Land location is expected to open in 2029. Learn more here: https://bit.ly/4jhNUyt #EndCancer

A new study from our researchers reveals a novel NK cell therapy that uses the bispecific antibody AFM13 led to a 92.9% response rate in patients with refractory CD30-positive lymphomas. This approach may offer a safer, effective option for those with limited treatment choices. Learn more. #EndCancer

Most cancer patients experience fatigue at some point, but what's the best course to manage this common side effect? Our Dr. Carmen Escalante and Dr. Lucy Potter discuss ways to manage and even improve fatigue symptoms. Listen here: https://brnw.ch/21wRM9I #EndCancer

A new study led by MD Anderson researchers maps how cancer-associated fibroblasts (CAFs) are spatially organized across tumor types. The team identified four conserved CAF subtypes tied to immune response, disease progression and outcomes — offering new insights for targeting the tumor microenvironment. Learn more. #EndCancer

"Every single person working here works here for a reason. We share a passion for our mission. We care. And I think that's what makes this place very special," says our Dr. Mariana Chavez Mac Gregor. Hear more from her as she shares the most rewarding part of her job. #EndCancer

Every day, we are grateful for our physicians who care for our patients and their families. This Doctors' Day, we acknowledge their dedication to advancing cancer care, research and our mission to #EndCancer.

Some patients with early-stage invasive breast cancer may not need surgery to stay cancer-free. In a Phase II trial led by our researchers, patients who had a complete response to chemotherapy and radiation remained cancer-free five years later — without surgery. "The absence of detectable breast cancer recurrences at the five-year mark highlights the tremendous potential of this surgery-free approach to breast cancer management," says our Dr. Henry Kuerer. Learn more. #EndCancer

Congratulations to our Dr. Lauren Byers and Dr. Paul Scheet on being elected AAAS Fellows. Learn more about this recognition. #EndCancer

"MD Anderson gave me that piece I was missing in my profession," says our Dr. David Ramirez. Read his story and how a medical rotation changed his life. #EndCancer

Congratulations to Jeffrey E. Lee, M.D. on his official appointment at MD Anderson’s Chief Medical Executive, effective April 1. "The opportunity to lead our incredibly talented team of clinicians, scientists and staff is a distinct honor,” Lee says. "Inspired by the needs of our patients and working under our shared mission, I’m committed to guiding our collective efforts to deliver powerful impact for our patients.” Learn about Dr. Lee’s 34-year tenure at MD Anderson, where he has made substantial contributions in oncology and served in multiple leadership roles: http://bit.ly/4cav61E #HealthCare #EndCancer